Logo image of AZE.BR

AZELIS GROUP NV (AZE.BR) Stock Fundamental Analysis

Europe - EBR:AZE - BE0974400328 - Common Stock

11.22 EUR
+0.39 (+3.6%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, AZE scores 5 out of 10 in our fundamental rating. AZE was compared to 14 industry peers in the Trading Companies & Distributors industry. There are concerns on the financial health of AZE while its profitability can be described as average. AZE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year AZE was profitable.
In the past year AZE had a positive cash flow from operations.
Each year in the past 5 years AZE has been profitable.
AZE had a positive operating cash flow in each of the past 5 years.
AZE.BR Yearly Net Income VS EBIT VS OCF VS FCFAZE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

The Return On Assets of AZE (2.99%) is comparable to the rest of the industry.
AZE has a Return On Equity (6.38%) which is comparable to the rest of the industry.
The Return On Invested Capital of AZE (5.90%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for AZE is in line with the industry average of 7.80%.
Industry RankSector Rank
ROA 2.99%
ROE 6.38%
ROIC 5.9%
ROA(3y)3.54%
ROA(5y)2.94%
ROE(3y)7.36%
ROE(5y)6.19%
ROIC(3y)6.56%
ROIC(5y)5.87%
AZE.BR Yearly ROA, ROE, ROICAZE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6 8

1.3 Margins

AZE has a better Profit Margin (4.01%) than 78.57% of its industry peers.
AZE's Profit Margin has improved in the last couple of years.
AZE has a Operating Margin of 8.62%. This is in the better half of the industry: AZE outperforms 78.57% of its industry peers.
AZE's Operating Margin has improved in the last couple of years.
AZE has a Gross Margin of 23.57%. This is comparable to the rest of the industry: AZE outperforms 57.14% of its industry peers.
In the last couple of years the Gross Margin of AZE has grown nicely.
Industry RankSector Rank
OM 8.62%
PM (TTM) 4.01%
GM 23.57%
OM growth 3Y4.8%
OM growth 5Y7.9%
PM growth 3Y21.4%
PM growth 5Y13.37%
GM growth 3Y1.74%
GM growth 5Y2.88%
AZE.BR Yearly Profit, Operating, Gross MarginsAZE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AZE is destroying value.
Compared to 1 year ago, AZE has about the same amount of shares outstanding.
AZE has more shares outstanding than it did 5 years ago.
AZE has a worse debt/assets ratio than last year.
AZE.BR Yearly Shares OutstandingAZE.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AZE.BR Yearly Total Debt VS Total AssetsAZE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

AZE has an Altman-Z score of 0.83. This is a bad value and indicates that AZE is not financially healthy and even has some risk of bankruptcy.
AZE's Altman-Z score of 0.83 is on the low side compared to the rest of the industry. AZE is outperformed by 92.86% of its industry peers.
AZE has a debt to FCF ratio of 6.96. This is a slightly negative value and a sign of low solvency as AZE would need 6.96 years to pay back of all of its debts.
The Debt to FCF ratio of AZE (6.96) is better than 64.29% of its industry peers.
AZE has a Debt/Equity ratio of 0.65. This is a neutral value indicating AZE is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.65, AZE is doing worse than 64.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.96
Altman-Z 0.83
ROIC/WACC0.87
WACC6.82%
AZE.BR Yearly LT Debt VS Equity VS FCFAZE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

AZE has a Current Ratio of 1.68. This is a normal value and indicates that AZE is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.68, AZE is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
AZE has a Quick Ratio of 1.05. This is a normal value and indicates that AZE is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.05, AZE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.05
AZE.BR Yearly Current Assets VS Current LiabilitesAZE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for AZE have decreased by -0.25% in the last year.
AZE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.29% yearly.
Looking at the last year, AZE shows a small growth in Revenue. The Revenue has grown by 1.70% in the last year.
The Revenue has been growing by 15.00% on average over the past years. This is quite good.
EPS 1Y (TTM)-0.25%
EPS 3Y36.76%
EPS 5Y29.29%
EPS Q2Q%-12.82%
Revenue 1Y (TTM)1.7%
Revenue growth 3Y14.23%
Revenue growth 5Y15%
Sales Q2Q%97.22%

3.2 Future

AZE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.83% yearly.
The Revenue is expected to grow by 5.13% on average over the next years.
EPS Next Y-12.17%
EPS Next 2Y0.94%
EPS Next 3Y4.28%
EPS Next 5Y7.83%
Revenue Next Year-0.59%
Revenue Next 2Y1.63%
Revenue Next 3Y2.93%
Revenue Next 5Y5.13%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AZE.BR Yearly Revenue VS EstimatesAZE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B 5B
AZE.BR Yearly EPS VS EstimatesAZE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.26, the valuation of AZE can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of AZE indicates a rather cheap valuation: AZE is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.69. AZE is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 11.59 indicates a reasonable valuation of AZE.
AZE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AZE is cheaper than 71.43% of the companies in the same industry.
AZE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.18.
Industry RankSector Rank
PE 16.26
Fwd PE 11.59
AZE.BR Price Earnings VS Forward Price EarningsAZE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AZE is valued a bit cheaper than 64.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AZE is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.22
EV/EBITDA 8.81
AZE.BR Per share dataAZE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The decent profitability rating of AZE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.56
EPS Next 2Y0.94%
EPS Next 3Y4.28%

3

5. Dividend

5.1 Amount

AZE has a Yearly Dividend Yield of 1.47%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of AZE has falen by -23.08%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
AZE's Dividend Yield is comparable with the industry average which is at 2.81.
AZE's Dividend Yield is slightly below the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.47%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
AZE.BR Yearly Dividends per shareAZE.BR Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

31.47% of the earnings are spent on dividend by AZE. This is a low number and sustainable payout ratio.
DP31.47%
EPS Next 2Y0.94%
EPS Next 3Y4.28%
AZE.BR Yearly Income VS Free CF VS DividendAZE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M
AZE.BR Dividend Payout.AZE.BR Dividend Payout, showing the Payout Ratio.AZE.BR Dividend Payout.PayoutRetained Earnings

AZELIS GROUP NV

EBR:AZE (10/20/2025, 7:00:00 PM)

11.22

+0.39 (+3.6%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-23 2025-10-23
Inst Owners51.94%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.74B
Analysts80
Price Target19.45 (73.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.47%
Yearly Dividend0.22
Dividend Growth(5Y)N/A
DP31.47%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.56%
PT rev (3m)-11.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-23.27%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)-4.44%
Valuation
Industry RankSector Rank
PE 16.26
Fwd PE 11.59
P/S 0.65
P/FCF 9.22
P/OCF 8.46
P/B 1.03
P/tB N/A
EV/EBITDA 8.81
EPS(TTM)0.69
EY6.15%
EPS(NY)0.97
Fwd EY8.63%
FCF(TTM)1.22
FCFY10.84%
OCF(TTM)1.33
OCFY11.83%
SpS17.33
BVpS10.89
TBVpS-4.3
PEG (NY)N/A
PEG (5Y)0.56
Profitability
Industry RankSector Rank
ROA 2.99%
ROE 6.38%
ROCE 7.86%
ROIC 5.9%
ROICexc 6.54%
ROICexgc 55.55%
OM 8.62%
PM (TTM) 4.01%
GM 23.57%
FCFM 7.02%
ROA(3y)3.54%
ROA(5y)2.94%
ROE(3y)7.36%
ROE(5y)6.19%
ROIC(3y)6.56%
ROIC(5y)5.87%
ROICexc(3y)7.11%
ROICexc(5y)6.31%
ROICexgc(3y)61.38%
ROICexgc(5y)55.63%
ROCE(3y)8.76%
ROCE(5y)7.85%
ROICexcg growth 3Y-2.57%
ROICexcg growth 5Y-2.01%
ROICexc growth 3Y5.64%
ROICexc growth 5Y8.86%
OM growth 3Y4.8%
OM growth 5Y7.9%
PM growth 3Y21.4%
PM growth 5Y13.37%
GM growth 3Y1.74%
GM growth 5Y2.88%
F-Score8
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.96
Debt/EBITDA 3.6
Cap/Depr 22.87%
Cap/Sales 0.63%
Interest Coverage 3.14
Cash Conversion 67.16%
Profit Quality 175.19%
Current Ratio 1.68
Quick Ratio 1.05
Altman-Z 0.83
F-Score8
WACC6.82%
ROIC/WACC0.87
Cap/Depr(3y)16.39%
Cap/Depr(5y)20.73%
Cap/Sales(3y)0.38%
Cap/Sales(5y)0.47%
Profit Quality(3y)207.45%
Profit Quality(5y)175.19%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.25%
EPS 3Y36.76%
EPS 5Y29.29%
EPS Q2Q%-12.82%
EPS Next Y-12.17%
EPS Next 2Y0.94%
EPS Next 3Y4.28%
EPS Next 5Y7.83%
Revenue 1Y (TTM)1.7%
Revenue growth 3Y14.23%
Revenue growth 5Y15%
Sales Q2Q%97.22%
Revenue Next Year-0.59%
Revenue Next 2Y1.63%
Revenue Next 3Y2.93%
Revenue Next 5Y5.13%
EBIT growth 1Y-4.3%
EBIT growth 3Y19.71%
EBIT growth 5Y24.08%
EBIT Next Year15.57%
EBIT Next 3Y9.34%
EBIT Next 5Y13.43%
FCF growth 1Y-33.39%
FCF growth 3Y62.82%
FCF growth 5Y37.19%
OCF growth 1Y-29.85%
OCF growth 3Y53.15%
OCF growth 5Y33.59%